0001567619-23-002883.txt : 20230214 0001567619-23-002883.hdr.sgml : 20230214 20230214160331 ACCESSION NUMBER: 0001567619-23-002883 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230214 DATE AS OF CHANGE: 20230214 EFFECTIVENESS DATE: 20230214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Athyrium Capital Management, LP CENTRAL INDEX KEY: 0001728001 IRS NUMBER: 263965190 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-18509 FILM NUMBER: 23628625 BUSINESS ADDRESS: STREET 1: 505 FIFTH AVENUE, FLOOR 18 CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 212-402-6925 MAIL ADDRESS: STREET 1: 505 FIFTH AVENUE, FLOOR 18 CITY: NEW YORK STATE: NY ZIP: 10017 13F-HR 1 primary_doc.xml X0202 13F-HR LIVE false true false 0001728001 XXXXXXXX 12-31-2022 12-31-2022 Athyrium Capital Management, LP

505 FIFTH AVENUE, FLOOR 18 NEW YORK NY 10017

13F HOLDINGS REPORT 028-18509 N Andrew Hyman 212-402-6925 /s/ Andrew Hyman New York NY 02-14-2023 0 11 237928239 false INFORMATION TABLE 2 form13fInfoTable.xml Biora Inc. COM 74319F107 5579088 42362097 SH SOLE NA 42362097 0 0 Biora Inc. Note 7.250% 12/0 74319FAB3 56262773 103500000 PRN SOLE NA 0 0 103500000 Amryt Pharma PLC Sponsored ADS 03217L106 64658056 8857268 SH SOLE NA 8857268 0 0 Societal CDMO Inc. Com 75629F109 3281606 2202420 SH SOLE NA 2202420 0 0 CAREMAX INC COM CL A 14171W103 16305349 4467219 SH SOLE NA 4467219 0 0 RVL PHARMACEUTICALS PLC SHS G6S41R101 16352497 14600444 SH SOLE NA 14600444 0 0 Omeros Corp NOTE 6.250%11/1 682143AE2 20240546 21005000 PRN SOLE NA 0 0 21005000 Omeros Corp NOTE 5.250% 2/1 682143AG7 31700772 58131000 PRN SOLE NA 0 0 58131000 BridgeBio Pharma Inc. NOTE 2.250% 2/0 10806XAD4 7753900 20000000 PRN SOLE NA 0 0 20000000 PUMA BIOTECHNOLOGY INC COM 74587V107 7580642 1792114 SH SOLE NA 1792114 0 0 Paratek Pharmaceuticals Inc. NOTE 4.750% 5/0 699374AB0 8213010 9000000 PRN SOLE NA 0 0 9000000